Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 95676 · Class III · Hoxworth Blood Center University of Cincinnati
Key facts
| Event ID | 95676 |
|---|---|
| Recall numbers | B-0094-2025 |
| Recalling firm | Hoxworth Blood Center University of Cincinnati |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Apheresis Red Blood Cells, for which a visual inspection was not performed or documented, was distributed. |
| Initiation date | Aug 29, 2024 |
| Report date | Nov 20, 2024 |
| Termination date | Nov 8, 2024 |
| City | Cincinnati |
| State | OH |
| Country | United States |
| FEI number | 1570969 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: